Tinnitus Treatment With Cochlear Implant in Single Sided Deafness

Status Completed

Clinical Trial Summary

Recent studies have reported successful reduction of tinnitus after cochlear implantation (CI) in most CI users, but the mechanisms of reduction and the amount of improvement is not fully understood. Especially, the relative role of peripheral and central auditory pathways is not clearly known. This study assessed the effect of CI electrical stimulation on tinnitus in subjects with unilateral tinnitus related to a single-sided deafness (SSD), and relative contributions of peripheral and central auditory pathways in tinnitus reduction.

Clinical Trial Description

Introduction: Continuous surgical, technological and audiological advances are responsible for the ever improvement of outcomes obtained through cochlear implants (CI) over the last decades. These positive observations have progressively led to the cautious extension of CI indications including patients with single-sided deafness (SSD). SSD patients are characterized by the loss of functional hearing in one ear, causing an impairment of binaural hearing abilities, with important difficulties for sound localization and speech in noise comprehension. These patients also often present invalidating tinnitus in the deaf ear, worsening both their psychological and audiological conditions. Recent studies have reported successful reduction of tinnitus intensity after cochlear implantation. However, most studies included a very limited number of participants and tinnitus evaluation tools. The impact of CI speech perception abilities in SSD is still under debate.

Objective: This study aims to assess the effect of CI electrical stimulation on tinnitus, speech-in-noise and speech-in-quiet abilities in a group of 30 SSD patients.

Methods: After cochlear implantation, patients are stimulated using continuous white noise stimulation in the first month period and thereafter using a conventional stimulation. This was done to investigate the effects of non-meaningful, and therefore only peripheral, stimulation. Outcomes were monitored at 1, 3, 6 and 12 months of CI use. Tinnitus loudness and annoyance were measured with a Visual Analog Scale and tinnitus distress and quality of life were evaluated with tinnitus questionnaires (THI, TRQ and STSS). Speech in noise comprehension was assessed in three different spatial listening configurations and speech in quiet was evaluated through direct connection with the speech processor. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02966366
Study type	Interventional
Source	Oticon Medical
Contact
Status	Completed
Phase	N/A
Start date	August 27, 2013
Completion date	March 7, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05963542` - Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia	N/A
Recruiting	`NCT04987502` - Virtual Reality and Subjective Tinnitus	N/A
Recruiting	`NCT04404439` - Treatment of Tinnitus With Migraine Medications	Phase 4
Recruiting	`NCT05533840` - Establishment and Application of a New Imaging System for Otology Based on Ultra-high Resolution CT
Completed	`NCT03552302` - Effects of Yoga Exercise on Participates With Tinnitus
Enrolling by invitation	`NCT02617953` - Objective Diagnosis Method and Efficacy of Repetitive Transcranial Magnetic Stimulation as a Treatment for Tinnitus	N/A
Completed	`NCT02269839` - A Feasibility Study Assessing the Effectiveness of rTMS in Tinnitus	N/A
Withdrawn	`NCT01663467` - Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy	N/A
Completed	`NCT02974543` - Somatosensory Stimulation to Alleviate Tinnitus	N/A
Completed	`NCT01929837` - Tinnitus rTMS 2013	N/A
Completed	`NCT01927991` - Internet-based Self-help for Tinnitus: The Role of Support	N/A
Completed	`NCT01857661` - The Influence of the Sound Generator Combined With Conventional Amplification for Tinnitus Control: Blind Randomized Clinical Trial	N/A
Terminated	`NCT01412918` - Inhibitor Masking Device & Sodium Channel, Voltage Gated, Type IX Alpha Subunit (SCN9) Gene Expression	N/A
Completed	`NCT01480193` - New Therapy for Patients With Severe Tinnitus	N/A
Completed	`NCT00371436` - Progressive Intervention Program for Tinnitus Management	N/A
Completed	`NCT00748475` - Countering Stimulus-Induced Alpha-Desynchronization to Treat Tinnitus	N/A
Completed	`NCT00733044` - Cost-effectiveness of Multidisciplinary Management of Tinnitus	N/A
Active, not recruiting	`NCT05518682` - Assessment of Bimodal Stimulation Device Compliance and Satisfaction in Individuals With Tinnitus	N/A
Recruiting	`NCT05212298` - Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus	N/A
Completed	`NCT06025097` - Intra-Tympanic Steroid With PRP Combination in Sensorineural Hearing Loss and Tinnitus.	Early Phase 1

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.